348 Results

People

  1. Giralt
    Giralt
  2. Lesokhin
    Lesokhin
  3. Korde
    Korde
  4. Hassoun
    Hassoun
  5. Landau
    Landau
  6. Mailankody
    Mailankody
  7. Shah
    Shah
  8. Chung
    Chung
  9. Landgren
    Landgren
  10. Hultcrantz
    Hultcrantz

Groups

  1. Center for Hematologic Malignancies (348)
  2. Department of Medicine (348)
  3. Hematologic Malignancies Research (348)
  4. Survivorship Research (348)
  5. Hematologic Malignancies, Division of (338)
  6. Bone Marrow Transplant (250)
  7. Myeloma (246)
  8. Epidemiology and Biostatistics (196)
  9. Biostatistics Service (169)
  10. Sloan Kettering Institute Postdocs (155)
  1. "Survivorship Research"
  2. "Hematologic Malignancies Research"
Formats
  1. Meeting Abstract (220)
  2. Journal Article (115)
  3. Research Letter (6)
  4. Book Section (3)
  5. Correspondence (2)
  6. Conference Paper (1)
  7. Review (1)
Groups
  1. Center for Hematologic Malignancies (348)
  2. Department of Medicine (348)
  3. Hematologic Malignancies Research (348)
  4. Survivorship Research (348)
  5. Hematologic Malignancies, Division of (338)
  6. Bone Marrow Transplant (250)

More Groups

People
  1. Sergio Giralt (188)
  2. Alexander Lesokhin (181)
  3. Neha Korde (175)
  4. Hani Hassoun (166)
  5. Heather Landau (161)
  6. Sham Mailankody (158)

More People

Years
  1. 2024 (2)
  2. 2023 (49)
  3. 2022 (39)
  4. 2021 (23)
  5. 2020 (33)
  6. 2019 (34)

More Years

Publications
  1. Blood (141)
  2. Biology of Blood and Marrow Transplantation (39)
  3. Clinical Lymphoma, Myeloma and Leukemia (34)
  4. Leukemia and Lymphoma (15)
  5. Journal of Clinical Oncology (14)
  6. Bone Marrow Transplantation (11)

More Publications

Publishers
  1. American Society of Hematology (151)
  2. Elsevier Inc. (77)
  3. Nature Publishing Group (28)
  4. American Society of Clinical Oncology (15)
  5. Taylor & Francis Group (15)
  6. American Association for Cancer Research (13)

More Publishers

Results (348)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction
    Journal Article

    Amor, C.; Fernández-Maestre, I.; Chowdhury, S.; Ho, Y. J.; Nadella, S.; Graham, C.; Carrasco, S. E.; Nnuji-John, E.; Feucht, J.; Hinterleitner, C.; more...
    Nature Aging (2024)

    Fulltext@MSK | Save
  • Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
    Journal Article

    Shah, U. A.; Moshier, E.; Derkach, A.; Huang, Y.; Mailankody, S.; Tan, C. R.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • T-cell exhaustion signature predicts early relapse after autologous stem cell transplant for multiple myeloma: BMT CTN 0702 secondary immune analysis
    Meeting Abstract

    Mehanna, N.; Derkach, A.; Gasmi, B.; Anagnostou, T.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Maclachlan, K. H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Journal Article

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The complex structural variant chromothripsis can be defined on targeted sequencing panels, allowing direct clinical translation in order to improve multiple myeloma prognostication
    Meeting Abstract

    Maclachlan, K. H.; Ziccheddu, B.; Tan, C.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Diamond, B.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Identifying causes of unscheduled healthcare interactions and changes to patient disposition in individuals receiving outpatient commercial bispecific antibody therapy in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Howard, A. J.; Shekarkhand, T.; Hamadeh, I. S.; Wang, A.; Patel, D.; Tan, C.; Hultcrantz, M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial
    Meeting Abstract

    Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
    Blood (2023)

    Fulltext@MSK | Save